Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT00673933 Completed - Acne Vulgaris Clinical Trials

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

Start date: May 2008
Phase: Phase 2
Study type: Interventional

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

NCT ID: NCT00671749 Completed - Acne Vulgaris Clinical Trials

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Start date: December 2007
Phase: Phase 4
Study type: Interventional

This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.

NCT ID: NCT00666900 Completed - Acne Vulgaris Clinical Trials

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

NCT ID: NCT00664248 Completed - Acne Vulgaris Clinical Trials

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

NCT ID: NCT00663286 Completed - Acne Vulgaris Clinical Trials

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

NCT ID: NCT00660985 Completed - Acne Vulgaris Clinical Trials

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

Start date: May 2008
Phase: Phase 4
Study type: Interventional

Phase 4 commitment pharmacokinetic study to determine systemic exposure to adapalene.

NCT ID: NCT00658112 Completed - Acne Vulgaris Clinical Trials

Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne

Start date: July 2006
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.

NCT ID: NCT00656981 Completed - Acne Vulgaris Clinical Trials

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Start date: January 2003
Phase: Phase 3
Study type: Interventional

The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles

NCT ID: NCT00651469 Completed - Acne Vulgaris Clinical Trials

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Start date: January 2003
Phase: Phase 3
Study type: Interventional

The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles.

NCT ID: NCT00635609 Completed - Acne Vulgaris Clinical Trials

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Start date: March 2008
Phase: Phase 4
Study type: Interventional

Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.